Terminated PHASE1 INTERVENTIONAL 1-arm NCT00550498

Stem Cell Transplantation in Ocular Lesions of Behcet's Disease

Phase 1 Study of Bone Marrow - Derived Stem Cell in the Treatment of Ocular Lesions of Behcet's Disease

Sponsor: Tehran University of Medical Sciences

Interventions Autologous Stem Cell Transplantation

Updated 6 times since 2017 Last updated: Nov 9, 2015 Started: Dec 31, 2007 Primary completion: Jul 31, 2012 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No improvement obtained in 3 cases. Retinal detachment observed in 2 cases

Other terminated trials from Tehran University of Medical Sciences

See all terminations from Tehran University of Medical Sciences

A PHASE1 clinical study on Behcet's Syndrome and Retinitis, this trial is terminated or withdrawn. The trial is conducted by Tehran University of Medical Sciences and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE1
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tehran University of Medical Sciences

Data source: Tehran University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tehran, Iran